Fabrice Ango Selected Research

Gonadotropin-Releasing Hormone (GnRH)

1/2017

Defective signaling through plexin-A1 compromises the development of the peripheral olfactory system and neuroendocrine reproductive axis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fabrice Ango Research Topics

Disease

2	Marijuana Abuse (Cannabis Abuse) 09/2022 - 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Schizophrenia (Dementia Praecox) 01/2020
1	Neurobehavioral Manifestations 01/2020
1	Dyskinesias (Dyskinesia) 01/2020
1	Anosmia 01/2017
1	Kallmann Syndrome (Kallmann's Syndrome) 01/2017
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2017
1	Motor Disorders 08/2014
1	Ataxia (Dyssynergia) 08/2014
1	Type 2 Episodic Ataxia 08/2014
1	Nervous System Diseases (Neurological Disorders) 08/2014
1	Episodic Ataxia 08/2014

Drug/Important Bio-Agent (IBA)

2	serotonin 6 receptorIBA 09/2022 - 01/2020
1	Dopamine (Intropin)FDA LinkGeneric 01/2020
1	Levodopa (L Dopa)FDA LinkGeneric 01/2020
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2020
1	Dronabinol (THC)FDA LinkGeneric 01/2020
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2020
1	Semaphorins (Semaphorin)IBA 01/2017
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2017
1	Acetazolamide (Diamox)FDA LinkGeneric 08/2014
1	Carbonic Anhydrase InhibitorsIBA 08/2014
1	Q-Type Calcium Channels (Q-Type Calcium Channel)IBA 08/2014
1	Calcium Channels (Calcium Channel)IBA 08/2014
1	Adrenergic Agents (Adrenergic Drugs)IBA 08/2014
1	voltage-dependent calcium channel (P-Q type)IBA 08/2014

Therapy/Procedure

1	Secondary Prevention 01/2020
1	Therapeutics 01/2020